MARKET

BCLI

BCLI

Brainstorm Cell Therapeutics I
NASDAQ
1.200
0.000
0.00%
After Hours: 1.180 -0.02 -1.67% 19:31 07/14 EDT
OPEN
1.200
PREV CLOSE
1.200
HIGH
1.200
LOW
1.170
VOLUME
172.88K
TURNOVER
--
52 WEEK HIGH
6.45
52 WEEK LOW
0.7233
MARKET CAP
9.53M
P/E (TTM)
-0.5948
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCLI last week (0707-0711)?
Weekly Report · 17h ago
Maxim Group Remains a Buy on Brainstorm Cell Therapeutics (BCLI)
TipRanks · 5d ago
BUZZ-BrainStorm Cell up after FDA considers Citizen Petition for ALS therapy review
Reuters · 6d ago
BRAINSTORM CELL THERAPEUTICS SHARES UP 5.3% PREMARKET AFTER FDA CONSIDERS CITIZEN PETITION FOR ALS THERAPY REVIEW
Reuters · 6d ago
BrainStorm Cell Therapeutics Inc. Announces Phase 3b Trial for ALS Treatment NurOwn, Reaffirming Commitment to Advancing Patient Access
Reuters · 6d ago
BRAINSTORM CELL THERAPEUTICS INC - TO CONTINUE PHASE 3B TRIAL FOR ALS
Reuters · 6d ago
Weekly Report: what happened at BCLI last week (0630-0704)?
Weekly Report · 07/07 11:35
Weekly Report: what happened at BCLI last week (0623-0627)?
Weekly Report · 06/30 11:43
More
About BCLI
Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease; progressive multiple sclerosis (PMS); Alzheimer’s disease (AD); and other neurodegenerative diseases. Its NurOwn, a cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived MSCs to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. It has completed a Phase III pivotal trial in ALS (NCT03280056); this trial investigated the safety and efficacy of repeat-administration of autologous MSC-NTF cells. The Company's wholly owned subsidiary, Brainstorm Cell Therapeutics Ltd. holds exclusive rights to commercialize NurOwn technology.

Webull offers Brainstorm Cell Therapeutics Inc stock information, including NASDAQ: BCLI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCLI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCLI stock methods without spending real money on the virtual paper trading platform.